Journal Home
Search for

Volume 22, Issue 3, Pages 121-125 (September 2010)


View previous. 9 of 15 View next.

Growing Rods in the Treatment of Congenital Spinal Deformity

Pooria Salari, MD, Behrooz A. Akbarnia, MDCorresponding Author Informationemail address, Hazem El-Sebaie, FRCS, MD, Muharrem Yazici, MD§

published online 10 June 2010.

By nature, congenital spinal deformity is always early in onset. Left untreated, many patients with progressive deformities of the spine and chest wall experience life-threatening complications. The goal of treatment is to improve the deformities and to allow the maximum potential growth of the spine and chest to occur. Therefore, non-fusion distraction-based procedures, such as growing rod (GR) or vertical expandable prosthetic titanium rib (VEPTR) are appealing. The GR procedure may be beneficial in the absence of multiple rib fusions, when the congenital anomaly involves a vertebral segment too long for resection, or with compensatory curve with structural pattern concomitant to the congenital deformity. There has been increasing interest in the use of GR techniques in congenital spine deformities in young children. Most recently results of GR application in congenital scoliosis patients with minimum 2 years follow-up have been presented by Growing Spine Study Group (GSSG). They reported 27% curve correction and 12 mm/year T1S1 growth at latest follow-up. Complications occurred in 8 of the 19 patients (42%), and complication rate per surgery was reported to be 15%. With proper patient selection, GR instrumentation is a useful technique in the treatment of selected cases of early-onset scoliosis caused by congenital spinal anomalies.

 San Diego Center for Spinal Disorders, La Jolla, CA

 Department of Orthopaedics, University of California, San Diego, CA

 Department of Orthopaedics, University of Cairo, Giza, Egypt

§ Department of Orthopaedics Sihhiye, Faculty of Medicine, Hacetteppe University, Ankara, Turkey

Corresponding Author InformationAddress reprint requests to Behrooz A. Akbarnia, MD, 4130 La Jolla Village Drive, Suite 300, La Jolla, CA 92037

PII: S1040-7383(10)00024-9

doi:10.1053/j.semss.2010.03.005


View previous. 9 of 15 View next.